Skip to main content
OpenTrials

Clinical trial condition

Atopic Dermatitis

Explore clinical trials studying Atopic Dermatitis. Study availability and eligibility vary by location and protocol.

857 public trials 113 recruiting studies
Refine in advanced search Browse all conditions

Atopic Dermatitis trial results

Completed

A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon)

NCT05651711

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Research Solutions of Arizona, PC Litchfield Park, Arizona, United States
  • Center for Dermatology and Plastic Surgery Scottsdale, Arizona, United States
  • Clinical Trials Institute of Northwest Arkansas Fayetteville, Arkansas, United States
  • Burke Pharmaceutical Research Hot Springs, Arkansas, United States
View all 197 locations
View Trial Details
Completed

Phase 2 Trial of HY209gel in Atopic Dermatitis Patients

NCT06024499

Conditions
Atopic Dermatitis, Atopic Dermatitis Eczema, Atopic Dermatitis of Scalp, +11 more
Locations
  • Cahaba Dermatology Skin Health Center Birmingham, Alabama, United States
  • RAOOF MD Dermatology Encino, California, United States
  • L.A. Universal Research Center, Inc. Los Angeles, California, United States
  • Zenith Research Inc. Los Angeles, California, United States
View Trial Details
Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses and Food Effect of BGB-45035 in Healthy Participants and in Adults With Autoimmune Dermatological Diseases

NCT06342713

Conditions
Atopic Dermatitis, Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +15 more
Locations
  • Innovate Clinical Research Waitara, New South Wales, Australia
  • Cmax Clinical Research Adelaide, South Australia, Australia
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
View all 13 locations
View Trial Details
Completed

Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema)

NCT03569293

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Alliance Dermatology and MOHs /ID# 200375 Phoenix, Arizona, United States
  • Clear Dermatology & Aesthetics Center /ID# 201256 Scottsdale, Arizona, United States
  • Bakersfield Derma & Skin Cance /ID# 200433 Bakersfield, California, United States
  • First OC Dermatology /ID# 201910 Fountain Valley, California, United States
View all 180 locations
View Trial Details
Completed

Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin Analysis

NCT05436535

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • University of California, San Diego: Dermatology Clinical Trials Unit La Jolla, California, United States
  • Children's Hospital Los Angeles: Division of Clinical Immunology & Allergy Los Angeles, California, United States
  • National Jewish Health: Division of Pediatric Allergy and Clinical Immunology Denver, Colorado, United States
  • Boston Children's Hospital: Department of Immunology Boston, Massachusetts, United States
View Trial Details
Completed

A Study to Evaluate Upadacitinib in Adolescents and Adults With Moderate to Severe Atopic Dermatitis (Measure Up 2)

NCT03607422

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Total Skin and Beauty Derm Ctr /ID# 205129 Birmingham, Alabama, United States
  • Medical Dermatology Specialist /ID# 205516 Phoenix, Arizona, United States
  • Arizona Research Center, Inc. /ID# 205795 Phoenix, Arizona, United States
  • The Dermatology Clinic of Arkansas /ID# 218749 Bryant, Arkansas, United States
View all 196 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy, and Safety Study of Ruxolitinib Cream in Adults With Moderate Atopic Dermatitis

NCT06238817

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +14 more
Locations
  • Lynn Institute of the Ozarks Little Rock, Arkansas, United States
  • First Oc Dermatology Fountain Valley, California, United States
  • Center For Dermatology Cosmetic and Laser Surgery Fremont, California, United States
  • Medderm Associates, Inc San Diego, California, United States
View all 94 locations
View Trial Details

Related conditions